Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 4
2006 5
2007 4
2008 4
2009 4
2010 5
2011 7
2012 8
2013 15
2014 12
2015 11
2016 18
2017 7
2018 12
2019 16
2020 16
2021 10
2022 14
2023 16
2024 16
2025 13
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Free PMC article. Clinical Trial.
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives.
Caridà G, Martino EA, Bruzzese A, Caracciolo D, Labanca C, Mendicino F, Lucia E, Olivito V, Rossi T, Neri A, Vigna E, Tassone P, Tagliaferri P, Morabito F, Gentile M. Caridà G, et al. Among authors: tagliaferri p. Eur J Haematol. 2025 May;114(5):775-784. doi: 10.1111/ejh.14401. Epub 2025 Feb 19. Eur J Haematol. 2025. PMID: 39971627 Free PMC article. Review.
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.
Marchetti P, Curigliano G, Biffoni M, Lonardi S, Scagnoli S, Fornaro L, Guarneri V, De Giorgi U, Ascierto PA, Blandino G, D'Amati G, Aglietta M, Cremolini C, Conte P, Crimini E, Ceracchi M, Pisegna S, Verkhovskaia S, Bordonaro R, Bracarda S, Butturini G, Del Mastro L, DeCensi A, Fabbri A, Fenocchio E, Gori S, Metro G, Pessino A, Pozzessere D, Puglisi F, Tamberi S, Zambelli A, Marino D, Capoluongo E, Cappuzzo F, Cerbelli B, Giannini G, Malapelle U, Mazzuca F, Nuti M, Pruneri G, Simmaco M, Strigari L, Tonini G, Martini N, Botticelli A; ROME trial investigators consortia. Marchetti P, et al. Nat Med. 2025 Oct;31(10):3514-3523. doi: 10.1038/s41591-025-03918-x. Epub 2025 Sep 29. Nat Med. 2025. PMID: 41023484 Free PMC article. Clinical Trial.
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.
Grillone K, Ascrizzi S, Cremaschi P, Amato J, Polerà N, Croci O, Rocca R, Riillo C, Conforti F, Graziano R, Brancaccio D, Caracciolo D, Alcaro S, Pagano B, Randazzo A, Tagliaferri P, Iorio F, Tassone P. Grillone K, et al. Among authors: tagliaferri p. Blood. 2024 Oct 17;144(16):1705-1721. doi: 10.1182/blood.2023021991. Blood. 2024. PMID: 39158066 Free PMC article.
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Cioli E, Latiano TP, De Stefano A, Tamburini E, Ramundo M, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Barruca V, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Normanno N, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: tagliaferri p. Eur J Cancer. 2025 Aug 26;226:115642. doi: 10.1016/j.ejca.2025.115642. Epub 2025 Jul 12. Eur J Cancer. 2025. PMID: 40669385 Clinical Trial.
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459 Free article.
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis.
Staropoli N, Ciliberto D, Luciano F, Napoli C, Costa M, Rossini G, Arbitrio M, Labanca C, Riillo C, Del Giudice T, Crispino A, Salvino A, Galvano A, Russo A, Tassone P, Tagliaferri P. Staropoli N, et al. Among authors: tagliaferri p. Crit Rev Oncol Hematol. 2024 Jan;193:104229. doi: 10.1016/j.critrevonc.2023.104229. Epub 2023 Dec 7. Crit Rev Oncol Hematol. 2024. PMID: 38065404 Free article.
Mir-34: a new weapon against cancer?
Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V, Zarone MR, Gullà A, Tagliaferri P, Tassone P, Caraglia M. Misso G, et al. Among authors: tagliaferri p. Mol Ther Nucleic Acids. 2014 Sep 23;3(9):e194. doi: 10.1038/mtna.2014.47. Mol Ther Nucleic Acids. 2014. PMID: 25247240 Free PMC article. Review.
212 results